Novel transcatheter spacer for tricuspid regurgitation

Flashlight

Feb 17
Novel transcatheter spacer for tricuspid regurgitation
Fabian Barbieri, Markus Reinthaler, et al.
An 81-year-old male patient with severe, functional tricuspid regurgitation underwent a novel transcutaneous implantation of a spacer device (Pivot Extend), resulting in a reduction in TR severity and improvement in right ventricular function.
open access

new issue

Feb 16
A new issue of EuroIntervention

A State-of-the-Art on adjunctive pharmacological strategies for residual risk; a consensus statement on day-case PCI; aspirin discontinuation timing in ACS; 7-year outcomes in COMPARE-ABSORB; the PINNACLE-I trial; a novel spacer for tricuspid regurgitation treatment; news from PCR; and more

A new issue of EuroIntervention

Viewpoint

Feb 16
PCR: a new era dawns
Bernard Prendergast

PCR announces a new era, with an expanded educational mission and commitment to advancing interventional cardiology through education, research, and innovation under a new leadership team.

free

Research Correspondence

Feb 13
DFA access compression in lower limb angioplasty
Róbert Bellavics, Zoltan Ruzsa, et al.
This study compared the safety and efficacy of two closure devices, StatSeal and TR Band, for distal foot artery access site closure in 150 patients undergoing lower-limb endovascular interventions. Both devices showed low access site complication rates.
DFA access compression in lower limb angioplasty

Original Research

Feb 11
Intrepid transapical TMVR 5-year outcomes
Gilbert H.L. Tang, Michael J. Reardon, et al.
This single-arm study evaluated the 5-year outcomes of the early-generation Intrepid transapical transcatheter mitral valve replacement system in high-risk patients with symptomatic ≥moderate-severe mitral regurgitation, observing sustained mitral regurgitation reduction and durable valve performance among survivors.
Intrepid transapical TMVR 5-year outcomes

Editorial

Feb 12
TMVR durability
Marianna Adamo, Elisa Pezzola
The content discusses the use of transcatheter edge-to-edge repair (TEER) for the treatment of mitral regurgitation, with data on patient characteristics, outcomes, and safety profiles.
free

Original Research

Feb 10
Intra-annular TAVI in small annuli
Stefano Cannata, Azeem Latib, et al.
This study compared the outcomes of TAVI using the self-expanding Navitor and balloon-expandable SAPIEN 3 Ultra transcatheter heart valves in patients with small aortic annuli. The Navitor device showed better hemodynamic performance but higher rates of mild paravalvular leak and permanent pacemaker implantation.
Intra-annular TAVI in small annuli
Turning Point Podcast Listen now


Retrieval of a stuck TAVI device

Flashlight

Feb 9
Retrieval of a stuck TAVI device
Masakazu Yasuda, Gaku Nakazawa, et al.
A 71-year-old male with schizophrenia and chronic subdural hematoma underwent urgent TAVI using a 26 mm SAPIEN 3 valve via left subclavian access. Prosthesis-balloon alignment failure and balloon rupture occurred, requiring retrieval of the stuck prosthesis and delivery system via the left ventricular apex.
open access

Receive our newsletter
Subscribe banner

Research Correspondence

Feb 9
Impact of coronary dominance on LM PCI prognosis
Yingyang Geng, Lei Song, et al.
This retrospective study found that left-dominant patients undergoing PCI for left main disease had a higher risk of long-term adverse events, particularly target vessel revascularization, compared to non-left-dominant patients.
Impact of coronary dominance on LM PCI prognosis

Research Correspondence

Feb 5
COMPARE trial: 5-year results
Tim Wittig, Sabine Steiner, et al.
The COMPARE trial found no significant difference in 5-year clinically driven target lesion revascularization rates between low-dose and high-dose paclitaxel-coated balloons for the treatment of femoropopliteal lesions in patients with lower limb peripheral artery disease.
COMPARE trial: 5-year results

Expert Review

Feb 4
3D ICE in structural heart disease
Sergio Berti, Ralph Stephan von Bardeleben, et al.
This expert review discusses the growing importance of intracardiac echocardiography (ICE), particularly 3D ICE, in guiding structural heart interventions due to its ability to provide high-resolution imaging of cardiac anatomy.
3D ICE in structural heart disease
free

Editorial

Feb 3
TAVI in small aortic roots
Francesco Maisano
The content discusses the evolution and future of transcatheter aortic valve implantation (TAVI) in the management of aortic stenosis, highlighting the need for further innovation to address unmet needs and enable better lifetime management of patients.
free

Original Research

Feb 2
Biomimetic balloon-expandable THV in SAA
Ole De Backer, Vinayak N. Bapat, et al.

The novel DurAVR transcatheter heart valve demonstrated high technical success, favorable 30-day clinical and hemodynamic outcomes, and a low rate of complications in patients with small aortic annuli.

Biomimetic balloon-expandable THV in SAA
open access

new issue

Feb 2
A new issue of EuroIntervention

An expert review on 3D intracardiac echocardiography; biomimetic balloon-expandable THV in small aortic annuli; intra-annular TAVI in small aortic annuli; 5-year outcomes of transapical transcatheter mitral valve replacement; impact of coronary dominance on left main PCI prognosis; 5-year outcomes of the COMPARE trial; distal foot artery access compression; the retrieval of a stuck TAVI device; and more...

A new issue of EuroIntervention

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved